Difference between revisions of "Team:Freiburg/Project/Overview"
| Line 474: | Line 474: | ||
<h2>Project Motivation</h2> | <h2>Project Motivation</h2> | ||
<p> | <p> | ||
| − | Serological tests are a key element in modern medicine. Especially | + | Serological tests are a key element in modern medicine. Especially when it comes to the detection and identification of infectious diseases, performing different blood tests is inevitable. Regardless of a patient having diffuse symptoms or being tested for a defined number of diseases, more than one serological test has to be performed each time. Many tests, many days of waiting and an increasing bill: For some infectious diseases every minute is important to life and not everyone can afford a long series of testing. What if there was a possibility to combine all tests in one single and affordable device? |
</p> | </p> | ||
</div> | </div> | ||
| Line 482: | Line 482: | ||
<p> | <p> | ||
The DiaCHIP is an innovative tool to screen for a broad range of antibodies present in serum. <br> | The DiaCHIP is an innovative tool to screen for a broad range of antibodies present in serum. <br> | ||
| − | Antibodies can be an indicator for an immune response towards an infection or a successful vaccination. <br> | + | Antibodies can be an indicator for an immune response towards an infection or a successful vaccination. <br> They also play an important role in the diagnosis of autoimmune diseases. <br> |
| − | Especially the ability to differentiate between life threatening diseases and | + | Especially the ability to differentiate between life threatening diseases and mild infections within a short time bears the potential to save lives. |
</p> | </p> | ||
<p> | <p> | ||
| − | Spotting diseases by detecting correspondent antibodies in a patient's serum is an established method in <a href="https://2015.igem.org/Team:Freiburg/Diagnostics" title="diagnostics_today">modern diagnostics</a>. The DiaCHIP makes it possible to screen for multiple specific antibodies simply using a drop of blood. | + | Spotting diseases by detecting correspondent antibodies in a patient's serum is an established method in <a href="https://2015.igem.org/Team:Freiburg/Diagnostics" title="diagnostics_today">modern diagnostics</a>. The DiaCHIP makes it possible to screen for multiple specific antibodies at once simply using a drop of blood. |
</p> | </p> | ||
</div> | </div> | ||
| Line 493: | Line 493: | ||
<h2>The Concept</h2> | <h2>The Concept</h2> | ||
<p> | <p> | ||
| − | The key feature of the DiaCHIP concept is the combination of on-demand protein synthesis and a novel method for label-free detection packed into one device. The idea is to overcome challenges commonly found in protein array production and preservation. In addition, results can be obtained in a time- and cost-efficient manner; with a device simple enough to be rebuilt by future iGEM | + | The key feature of the DiaCHIP concept is the combination of on-demand protein synthesis and a novel method for label-free detection packed into one device. The idea is to overcome challenges commonly found in protein array production and preservation. In addition, results can be obtained in a time- and cost-efficient manner; with a device simple enough to be rebuilt by future iGEM Teams. |
</p> | </p> | ||
</div> | </div> | ||
| Line 518: | Line 518: | ||
<div class="slidertext"> | <div class="slidertext"> | ||
<h1>Building our own device</h1> | <h1>Building our own device</h1> | ||
| − | <p>The device originally used, in collaboration with AG Roth, is | + | <p>The device originally used, in collaboration with AG Roth, is an expensive machine based on rather simple components. Therefore, we decided to build our apparatus in a cost-efficient manner. We were able to produce reliable results with it and provide a <a href="https://2015.igem.org/Team:Freiburg/Results/Own_Device#how_to_build_your_own_device">construction plan</a>. This plan will make it possible for future iGEM generations to build and use their own label-free protein array analysis tool.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| − | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/OwnDevice"> more | + | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/OwnDevice">more</a>? |
</p> | </p> | ||
</div> | </div> | ||
| Line 533: | Line 533: | ||
<div class="slidertext"> | <div class="slidertext"> | ||
<h1>Communicating science</h1> | <h1>Communicating science</h1> | ||
| − | <p>Diagnosing diseases fast and reliable is not only an issue among medical staff, it is also subject to public interest. This has lead us to ask for people's opinions regarding the DiaCHIP. Although the method is based on synthetic biology, which is a problematic | + | <p>Diagnosing diseases fast and reliable is not only an issue among medical staff, it is also subject to public interest. This has lead us to ask for people's opinions regarding the DiaCHIP. Although the method is based on synthetic biology, which is a problematic term for the broad public according to a survey initiated by the Leopoldina (National academy of science), we received a lot of positive feedback. </p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| − | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Practices"> more | + | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Practices">more</a>?</p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 546: | Line 546: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Modeling | + | <h1>Modeling cell-free expression</h1> |
| − | <p>In order to optimize the DiaCHIP for future applications, we optimized the process of cell-free expression and diffusion over time. Making use of xxx parameters and xxx ordinary differential equations, we computed the size of the resulting antigen spots and identified the factors limiting cell-free expression in the DiaCHIP. </p> | + | <p>In order to optimize the DiaCHIP for future applications, we optimized the process of cell-free expression and diffusion over time. Making use of xxx parameters and xxx ordinary differential equations, we computed the size of the resulting antigen spots on the protein array and identified the factors limiting cell-free expression in the DiaCHIP. </p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| − | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Modeling">more | + | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Modeling">more</a>? </p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 560: | Line 560: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Measuring our | + | <h1>Measuring our blood</h1> |
| − | <p>One of the most promising results | + | <p>One of the most promising results was obtained from the detection of anti-tetanus antibodies in human blood serum. The DiaCHIP analysis made it possible for us to distinguish serum samples from a team member before and after vaccination. Samples taken two weeks after vaccination produced higher signals, compared to those prior to antigen exposure.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| − | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Results">more | + | <p> Want to read <a href="https://2015.igem.org/Team:Freiburg/Results">more</a>?</p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 574: | Line 574: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Measuring our | + | <h1>Measuring our blood</h1> |
| − | <p>One of the most promising results | + | <p>One of the most promising results was obtained from the detection of anti-tetanus antibodies in human blood serum. The DiaCHIP analysis made it possible for us to distinguish serum samples from a team member before and after vaccination. Samples taken two weeks after vaccination produced higher signals, compared to those prior to antigen exposure.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| Line 588: | Line 588: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Measuring our | + | <h1>Measuring our blood</h1> |
| − | <p>One of the most promising results | + | <p>One of the most promising results was obtained from the detection of anti-tetanus antibodies in human blood serum. The DiaCHIP analysis made it possible for us to distinguish serum samples from a team member before and after vaccination. Samples taken two weeks after vaccination produced higher signals, compared to those prior to antigen exposure.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| Line 602: | Line 602: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Measuring our | + | <h1>Measuring our blood</h1> |
| − | <p>One of the most promising results | + | <p>One of the most promising results was obtained from the detection of anti-tetanus antibodies in human blood serum. The DiaCHIP analysis made it possible for us to distinguish serum samples from a team member before and after vaccination. Samples taken two weeks after vaccination produced higher signals, compared to those prior to antigen exposure.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
| Line 616: | Line 616: | ||
</div> | </div> | ||
<div class="slidertext"> | <div class="slidertext"> | ||
| − | <h1>Measuring our | + | <h1>Measuring our blood</h1> |
| − | <p>One of the most promising results | + | <p>One of the most promising results was obtained from the detection of anti-tetanus antibodies in human blood serum. The DiaCHIP analysis made it possible for us to distinguish serum samples from a team member before and after vaccination. Samples taken two weeks after vaccination produced higher signals, compared to those prior to antigen exposure.</p> |
</div> | </div> | ||
<div class="slidertext indent"> | <div class="slidertext indent"> | ||
Revision as of 20:37, 15 September 2015
The DiaCHIP - A Versatile Detection System
Project Motivation
Serological tests are a key element in modern medicine. Especially when it comes to the detection and identification of infectious diseases, performing different blood tests is inevitable. Regardless of a patient having diffuse symptoms or being tested for a defined number of diseases, more than one serological test has to be performed each time. Many tests, many days of waiting and an increasing bill: For some infectious diseases every minute is important to life and not everyone can afford a long series of testing. What if there was a possibility to combine all tests in one single and affordable device?
Detecting Antigen-Antibody Interactions
The DiaCHIP is an innovative tool to screen for a broad range of antibodies present in serum.
Antibodies can be an indicator for an immune response towards an infection or a successful vaccination.
They also play an important role in the diagnosis of autoimmune diseases.
Especially the ability to differentiate between life threatening diseases and mild infections within a short time bears the potential to save lives.
Spotting diseases by detecting correspondent antibodies in a patient's serum is an established method in modern diagnostics. The DiaCHIP makes it possible to screen for multiple specific antibodies at once simply using a drop of blood.
The Concept
The key feature of the DiaCHIP concept is the combination of on-demand protein synthesis and a novel method for label-free detection packed into one device. The idea is to overcome challenges commonly found in protein array production and preservation. In addition, results can be obtained in a time- and cost-efficient manner; with a device simple enough to be rebuilt by future iGEM Teams.
